Identification of immunodominant proteins of Leishmania infantum by immunoproteomics to evaluate a recombinant multi-epitope designed antigen for serodiagnosis of human visceral leishmaniasis
- PMID: 33428893
- DOI: 10.1016/j.exppara.2021.108065
Identification of immunodominant proteins of Leishmania infantum by immunoproteomics to evaluate a recombinant multi-epitope designed antigen for serodiagnosis of human visceral leishmaniasis
Abstract
Visceral leishmaniasis (VL) is a protozoan disease caused by Leishmania infantum in the Mediterranean region including Iran. In 95% of cases, the disease can be fatal if not rapidly diagnosed and left untreated. We aimed to identify immunoreactive proteins of L. infantum (Iranian strain), and to design and evaluate a recombinant multi-epitope antigen for serodiagnosis of human VL. To detect the immunoreactive proteins of L. infantum promastigotes, 2DE immunoblotting technique was performed using different pooled sera of VL patients. The candidate immunoreactive proteins were identified using MALDI-TOF/TOF mass spectrophotometry. Among 125 immunoreactive spots detected in 2-DE gels, glucose-regulated protein 78 (GRP78), ubiquitin-conjugating enzyme E2, calreticulin, mitochondrial heat shock 70-related protein 1 (mtHSP70), heat shock protein 70-related protein, i/6 autoantigen-like protein, ATPase beta subunit, and proteasome alpha subunit 5 were identified. The potent epitopes from candidate immunodominant proteins including GRP78, mtHSP70 and ubiquitin-conjugating enzyme E2 were then selected to design a recombinant antigenic protein (GRP-UBI-HSP). The recombinant antigen was evaluated by ELISA and compared to direct agglutination test for detection of anti L. infantum human antibodies. We screened 34 sera of VL patients from endemic areas and 107 sera of individuals without L. infantum infection from non-endemic area of VL. The recombinant protein-based ELISA provided a sensitivity of 70.6% and a specificity of 84.1%. These results showed that GRP78, ubiquitin-conjugating enzyme E2, and mtHSP70 proteins are potential immunodominant targets of the host immune system in response to the parasite and they can be considered as potential candidate markers for diagnosis purposes.
Keywords: Diagnosis; Immunoreactive protein; Leishmania infantum; Multi-epitope polypeptide; Proteomics; Visceral leishmaniasis.
Copyright © 2021. Published by Elsevier Inc.
Similar articles
-
Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis.Clin Diagn Lab Immunol. 2005 May;12(5):647-53. doi: 10.1128/CDLI.12.5.647-653.2005. Clin Diagn Lab Immunol. 2005. PMID: 15879027 Free PMC article.
-
An immunoproteomic approach to identifying immunoreactive proteins in Leishmania infantum amastigotes using sera of dogs infected with canine visceral leishmaniasis.Pathog Glob Health. 2019 May;113(3):124-132. doi: 10.1080/20477724.2019.1616952. Epub 2019 May 17. Pathog Glob Health. 2019. PMID: 31099725 Free PMC article.
-
A Leishmania infantum hypothetical protein evaluated as a recombinant protein and specific B-cell epitope for the serodiagnosis and prognosis of visceral leishmaniasis.Acta Trop. 2020 Mar;203:105318. doi: 10.1016/j.actatropica.2019.105318. Epub 2019 Dec 20. Acta Trop. 2020. PMID: 31870709
-
A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis.Parasitol Res. 2016 Apr;115(4):1649-58. doi: 10.1007/s00436-016-4904-x. Epub 2016 Jan 19. Parasitol Res. 2016. PMID: 26782811 Review.
-
Place of Serology in the Diagnosis of Zoonotic Leishmaniases With a Focus on Visceral Leishmaniasis Due to Leishmania infantum.Front Cell Infect Microbiol. 2020 Feb 25;10:67. doi: 10.3389/fcimb.2020.00067. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32158704 Free PMC article. Review.
Cited by
-
In silico designing of a recombinant multi-epitope antigen for leprosy diagnosis.J Genet Eng Biotechnol. 2022 Sep 2;20(1):128. doi: 10.1186/s43141-022-00411-7. J Genet Eng Biotechnol. 2022. PMID: 36053342 Free PMC article.
-
Immunoproteomics and phage display in the context of leishmaniasis complexity.Front Immunol. 2023 Feb 8;14:1112894. doi: 10.3389/fimmu.2023.1112894. eCollection 2023. Front Immunol. 2023. PMID: 36845148 Free PMC article. Review.
-
Amphotericin B-Loaded Extracellular Vesicles Derived from Leishmania major Enhancing Cutaneous Leishmaniasis Treatment through In Vitro and In Vivo Studies.Iran J Parasitol. 2023 Oct-Dec;18(4):514-525. doi: 10.18502/ijpa.v18i4.14260. Iran J Parasitol. 2023. PMID: 38169565 Free PMC article.
-
Leishmania infantum UBC1 in Metacyclic Promastigotes from Phlebotomus perniciosus, a Vaccine Candidate for Zoonotic Visceral Leishmaniasis.Vaccines (Basel). 2022 Feb 3;10(2):231. doi: 10.3390/vaccines10020231. Vaccines (Basel). 2022. PMID: 35214689 Free PMC article.
-
The many faces of parasite calreticulin.Front Immunol. 2023 Mar 10;14:1101390. doi: 10.3389/fimmu.2023.1101390. eCollection 2023. Front Immunol. 2023. PMID: 36993959 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous